I have no idea whether they dosed any COVID patients before the trial or not but the quote from the CHED interview below seems that they might have given it to non-COVID patients and are hoping for similar results.

"we'll be able to to see the results so that they mimic what's been published on our drug as well as what we have already done in our drug in non-COVID patients,     we expect a very solid response!"